INTS Intensity Therapeutics, Inc.
$3.80
Intensity Therapeutics, Inc. (INTS) Earnings News
Earnings press releases, previews and reviews for Intensity Therapeutics, Inc. (INTS), newest first.
Tuesday
September 8, 2026
8:00 AM ET
Intensity Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Tuesday
August 11, 2026
7:30 AM ET
Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Tuesday
August 4, 2026
8:00 AM ET
Intensity Therapeutics to Announce Second Quarter 2026 Financial Results on August 11, 2026
Wednesday
July 15, 2026
7:45 AM ET
Intensity Therapeutics, Inc. Restarts Patient Treatment in the Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Trial (INVINCIBLE-4 Study)
Wednesday
July 1, 2026
8:00 AM ET
Intensity Therapeutics Provides Mid-Year Update Highlighting Late-Stage Development Programs and Strategic Partnering Opportunities for INT230-6
Thursday
May 14, 2026
8:00 AM ET
Intensity Therapeutics Recognized with GHP Magazine's 2026 Healthcare & Pharmaceutical Award
Thursday
May 7, 2026
4:06 PM ET
Intensity Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Wednesday
April 15, 2026
9:15 AM ET
Intensity Therapeutics Recognized with Pinnacle Award for Excellence in Healthcare Innovation